{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:19:38Z","timestamp":1785853178421,"version":"3.56.0"},"reference-count":33,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.3892\/or.2016.4926","type":"journal-article","created":{"date-parts":[[2016,7,11]],"date-time":"2016-07-11T08:10:52Z","timestamp":1468224652000},"page":"1592-1604","source":"Crossref","is-referenced-by-count":15,"title":["Analysis of the gene expression profile in response to human epididymis protein 4 in epithelial ovarian cancer cells"],"prefix":"10.3892","volume":"36","author":[{"given":"Liancheng","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyu","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanjuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,7,11]]},"reference":[{"key":"key20180107220942_b1-or-36-03-1592","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"key20180107220942_b2-or-36-03-1592","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.critrevonc.2010.07.004","article-title":"Epithelial ovarian cancer: Focus on targeted therapy","volume":"79","author":"Pliarchopoulou","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"key":"key20180107220942_b3-or-36-03-1592","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0378-1119(99)00342-X","article-title":"Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas","volume":"238","author":"Schummer","year":"1999","journal-title":"Gene"},{"key":"key20180107220942_b4-or-36-03-1592","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1745-7262.2007.00309.x","article-title":"Extracellular quality control in the epididymis","volume":"9","author":"Cornwall","year":"2007","journal-title":"Asian J Androl"},{"key":"key20180107220942_b5-or-36-03-1592","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ygyno.2015.06.021","article-title":"A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer - An international multicenter study in women with an ovarian mass","volume":"138","author":"Karlsen","year":"2015","journal-title":"Gynecol Oncol"},{"key":"key20180107220942_b6-or-36-03-1592","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ygyno.2016.01.016","article-title":"HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: An Italian multicenter study","volume":"141","author":"Romagnolo","year":"2016","journal-title":"Gynecol Oncol"},{"key":"key20180107220942_b7-or-36-03-1592","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3802\/jgo.2015.26.1.46","article-title":"Distinguishing benign from malignant pelvic mass utilizing an algorithm with HE4, menopausal status, and ultrasound findings","volume":"26","author":"Wilailak","year":"2015","journal-title":"J Gynecol Oncol"},{"key":"key20180107220942_b8-or-36-03-1592","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7314\/APJCP.2014.15.1.101","article-title":"HE4 as a serum biomarker for ROMA prediction and prognosis of epithelial ovarian cancer","volume":"15","author":"Chen","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20180107220942_b9-or-36-03-1592","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1007\/s13277-014-1836-x","article-title":"Can HE4 predict platinum response during first-line chemotherapy in ovarian cancer?","volume":"35","author":"Angioli","year":"2014","journal-title":"Tumour Biol"},{"key":"key20180107220942_b10-or-36-03-1592","doi-asserted-by":"crossref","first-page":"12389","DOI":"10.1007\/s13277-014-2553-1","article-title":"Serum HE4 and CA125 as predictors of response and outcome during neoadjuvant chemotherapy of advanced high-grade serous ovarian cancer","volume":"35","author":"Vallius","year":"2014","journal-title":"Tumour Biol"},{"key":"key20180107220942_b11-or-36-03-1592","first-page":"830","article-title":"Membranous expressions of Lewis y and CAM-DR-related markers are independent factors of chemotherapy resistance and poor prognosis in epithelial ovarian cancer","volume":"5","author":"Zhu","year":"2015","journal-title":"Am J Cancer Res"},{"key":"key20180107220942_b12-or-36-03-1592","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ygyno.2015.11.020","article-title":"Diagnostic and prognostic values of preoperative serum levels of YKL-40, HE-4 and DKK-3 in endometrial cancer","volume":"140","author":"Kemik","year":"2016","journal-title":"Gynecol Oncol"},{"key":"key20180107220942_b13-or-36-03-1592","first-page":"437468","article-title":"Expression of HE4 in endometrial cancer and its clinical significance","volume":"2015","author":"Li","year":"2015","journal-title":"Biomed Res Int"},{"key":"key20180107220942_b14-or-36-03-1592","first-page":"5568","article-title":"Expression level of serum human epididymis 4 and its prognostic significance in human non-small cell lung cancer","volume":"7","author":"Jiang","year":"2014","journal-title":"Int J Clin Exp Med"},{"key":"key20180107220942_b15-or-36-03-1592","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.3390\/ijms16022956","article-title":"Expression and diagnostic value of HE4 in pancreatic adenocarcinoma","volume":"16","author":"Huang","year":"2015","journal-title":"Int J Mol Sci"},{"key":"key20180107220942_b16-or-36-03-1592","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12094-015-1375-y","article-title":"Serum human epididymis protein 4 is associated with the treatment response of concurrent chemoradiotherapy and prognosis in patients with locally advanced non-small cell lung cancer","volume":"18","author":"Lan","year":"2016","journal-title":"Clin Transl Oncol"},{"key":"key20180107220942_b17-or-36-03-1592","doi-asserted-by":"crossref","first-page":"e0128836","DOI":"10.1371\/journal.pone.0128836","article-title":"Serum HE4: An independent prognostic factor in non-small cell lung cancer","volume":"10","author":"Lamy","year":"2015","journal-title":"PLoS One"},{"key":"key20180107220942_b18-or-36-03-1592","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.bbrc.2012.02.008","article-title":"Human epididymis protein 4 (HE4) plays a key role in ovarian cancer cell adhesion and motility","volume":"419","author":"Lu","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107220942_b19-or-36-03-1592","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1038\/srep03574","article-title":"HE4 (WFDC2) gene overexpression promotes ovarian tumor growth","volume":"4","author":"Moore","year":"2014","journal-title":"Sci Rep"},{"key":"key20180107220942_b20-or-36-03-1592","doi-asserted-by":"crossref","first-page":"729","DOI":"10.18632\/oncotarget.6327","article-title":"Overexpression of HE4 (human epididymis protein 4) enhances proliferation, invasion and metastasis of ovarian cancer","volume":"7","author":"Zhu","year":"2016","journal-title":"Oncotarget"},{"key":"key20180107220942_b21-or-36-03-1592","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3892\/or.2012.2114","article-title":"WAP four-disulfide core domain protein 2 mediates the proliferation of human ovarian cancer cells through the regulation of growth-and apoptosis-associated genes","volume":"29","author":"Chen","year":"2013","journal-title":"Oncol Rep"},{"key":"key20180107220942_b22-or-36-03-1592","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3892\/or.2014.3549","article-title":"Promotive role of recombinant HE4 protein in proliferation and carboplatin resistance in ovarian cancer cells","volume":"33","author":"Wang","year":"2015","journal-title":"Oncol Rep"},{"key":"key20180107220942_b23-or-36-03-1592","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/1476-4598-13-243","article-title":"Human epididymis protein 4 in association with Annexin II promotes invasion and metastasis of ovarian cancer cells","volume":"13","author":"Zhuang","year":"2014","journal-title":"Mol Cancer"},{"key":"key20180107220942_b24-or-36-03-1592","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.biochi.2014.06.022","article-title":"Overexpression of Lewis y antigen promotes human epididymis protein 4-mediated invasion and metastasis of ovarian cancer cells","volume":"105","author":"Zhuang","year":"2014","journal-title":"Biochimie"},{"key":"key20180107220942_b25-or-36-03-1592","doi-asserted-by":"crossref","first-page":"142","DOI":"10.12688\/f1000research.4573.1","article-title":"Development and use of the Cytoscape app GFD-Net for measuring semantic dissimilarity of gene networks","volume":"3","author":"Diaz-Montana","year":"2014","journal-title":"F1000Res"},{"key":"key20180107220942_b26-or-36-03-1592","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/01.ATV.0000256471.22437.88","article-title":"Heparin cofactor II modulates the response to vascular injury","volume":"27","author":"Tollefsen","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20180107220942_b27-or-36-03-1592","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.yexmp.2009.09.003","article-title":"Heparin cofactor II in atherosclerotic lesions from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study","volume":"87","author":"Rau","year":"2009","journal-title":"Exp Mol Pathol"},{"key":"key20180107220942_b28-or-36-03-1592","doi-asserted-by":"crossref","first-page":"34256","DOI":"10.1074\/jbc.M112.353532","article-title":"Heparin cofactor II, a serine protease inhibitor, promotes angiogenesis via activation of the AMP-activated protein kinase-endothelial nitric-oxide synthase signaling pathway","volume":"287","author":"Ikeda","year":"2012","journal-title":"J Biol Chem"},{"key":"key20180107220942_b29-or-36-03-1592","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/path.4421","article-title":"Heparin co-factor II enhances cell motility and promotes metastasis in non-small cell lung cancer","volume":"235","author":"Liao","year":"2015","journal-title":"J Pathol"},{"key":"key20180107220942_b30-or-36-03-1592","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-016-0055-6","article-title":"A panel of glycoproteins as candidate biomarkers for early diagnosis and treatment evaluation of B-cell acute lymphoblastic leukemia","volume":"4","author":"Cavalcante","year":"2016","journal-title":"Biomark Res"},{"key":"key20180107220942_b31-or-36-03-1592","doi-asserted-by":"crossref","first-page":"e68994","DOI":"10.1371\/journal.pone.0068994","article-title":"Co-expression of Lewis y antigen with human epididymis protein 4 in ovarian epithelial carcinoma","volume":"8","author":"Zhuang","year":"2013","journal-title":"PLoS One"},{"key":"key20180107220942_b32-or-36-03-1592","doi-asserted-by":"crossref","first-page":"6026","DOI":"10.3390\/ijms14036026","article-title":"HE4 (WFDC2) promotes tumor growth in endometrial cancer cell lines","volume":"14","author":"Li","year":"2013","journal-title":"Int J Mol Sci"},{"key":"key20180107220942_b33-or-36-03-1592","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3892\/or.2015.4339","article-title":"Recombinant HE4 protein promotes proliferation of pancreatic and endometrial cancer cell lines","volume":"35","author":"Lu","year":"2016","journal-title":"Oncol Rep"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2016.4926\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T00:07:06Z","timestamp":1568160426000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2016.4926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,11]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,7,11]]},"published-print":{"date-parts":[[2016,9]]}},"alternative-id":["10.3892\/or.2016.4926"],"URL":"https:\/\/doi.org\/10.3892\/or.2016.4926","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,11]]}}}